Login / Signup

KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins.

Giusi MarroneRaquel Maeso-DíazGuillermo García-CardenaJuan G AbraldesJuan Carlos García-PagánJaime BoschJordi Gracia-Sancho
Published in: Gut (2014)
Exogenous hepatic KLF2 upregulation improves liver fibrosis, endothelial dysfunction and portal hypertension in cirrhosis.
Keyphrases
  • liver fibrosis
  • blood pressure
  • transcription factor
  • cardiovascular disease
  • poor prognosis
  • cell proliferation
  • oxidative stress
  • type diabetes
  • arterial hypertension